Neural Regeneration Research ›› 2024, Vol. 20 ›› Issue (2): 574-586.doi: 10.4103/NRR.NRR-D-23-00595

Previous Articles     Next Articles

Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson’s disease

Olivier Kerdiles1, 2, 3, 4, #, Méryl-Farelle Oye Mintsa Mi-mba1, 2, 3, 4, #, Katherine Coulombe2, Cyntia Tremblay2, 4, Vincent Émond2, 4, Martine Saint-Pierre2, Clémence Rouxel2, 3, Line Berthiaume5, 6, Pierre Julien5, 6, Francesca Cicchetti2, 7, Frédéric Calon1, 2, 3, 4, *   

  1. 1Faculté de pharmacie, Université Laval, 1050 Avenue de la Médecine, Quebec, QC, Canada; 2Axe Neuroscience, Centre de recherche du CHU de Québec-Université Laval (Pavillon CHUL), 2705 Boulevard Laurier, Quebec, QC, Canada; 3Institute of Nutrition and Functional Foods, Quebec, QC, Canada; 4Optinutribrain International Associated Laboratory (NutriNeuro, France; INAF, Canada), Quebec, QC, Canada; 5Axe Endocrinologie et Néphrologie, Centre de recherche du CHU de Québec-Université Laval, Quebec, QC, Canada; 6Département de Médecine, Faculté de Médecine, Université Laval, Quebec, QC, Canada; 7Département de Psychiatrie et Neurosciences, Faculté de Médecine, Quebec, QC, Canada
  • Online:2025-02-15 Published:2024-06-18
  • Contact: Frédéric Calon, PhD, frederic.calon@crchudequebec.ulaval.ca.
  • Supported by:
    This study was supported by funding from Parkinson Canada. OK was funded by a scholarship from Parkinson Canada and a scholarship from Fonds d’Enseignement et de Recherche (FER) (Faculty of Pharmacy, Université Laval). FCa and FCi are both recipients of Researcher Chairs from the Fonds de Recherche du Québec en Santé (FRQS) providing salary support and operating funds.

Abstract: There is a need to develop interventions to slow or reverse the degeneration of dopamine neurons in Parkinson’s disease after diagnosis. Given that preclinical and clinical studies suggest benefits of dietary n-3 polyunsaturated fatty acids, such as docosahexaenoic acid, and exercise in Parkinson’s disease, we investigated whether both could synergistically interact to induce recovery of the dopaminergic pathway. First, mice received a unilateral stereotactic injection of 6-hydroxydopamine into the striatum to establish an animal model of nigrostriatal denervation. Four weeks after lesion, animals were fed a docosahexaenoic acid-enriched or a control diet for the next 8 weeks. During this period, the animals had access to a running wheel, which they could use or not. Docosahexaenoic acid treatment, voluntary exercise, or the combination of both had no effect on (i) distance traveled in the open field test, (ii) the percentage of contraversive rotations in the apomorphine-induction test or (iii) the number of tyrosine-hydroxylase-positive cells in the substantia nigra pars compacta. However, the docosahexaenoic acid diet increased the number of tyrosine-hydroxylase-positive terminals and induced a rise in dopamine concentrations in the lesioned striatum. Compared to docosahexaenoic acid treatment or exercise alone, the combination of docosahexaenoic acid and exercise (i) improved forelimb balance in the stepping test, (ii) decreased the striatal DOPAC/dopamine ratio and (iii) led to increased dopamine transporter levels in the lesioned striatum. The present results suggest that the combination of exercise and docosahexaenoic acid may act synergistically in the striatum of mice with a unilateral lesion of the dopaminergic system and provide support for clinical trials combining nutrition and physical exercise in the treatment of Parkinson’s disease.

Key words: 6-hydroxydopamine, dopamine, dopamine transporter, exercise, neurorestoration, Parkinson’s disease, polyunsaturated fatty acids omega-3